Description
Humulin R 100 IU/ml Vial is a pharmaceutical product manufactured by Lilly. It contains Insulin as its active substance and is primarily used in the management of diabetes mellitus. Humulin R is a short-acting insulin formulation that helps control blood sugar levels in individuals with diabetes. It is available in vial form, with each vial containing 10 milliliters (ml) of solution.
Active Substance:
The active substance in Humulin R is Insulin, a hormone produced by the pancreas that regulates glucose metabolism in the body. Insulin facilitates the uptake of glucose from the bloodstream into cells, where it is used for energy production or stored for future use. In individuals with diabetes, either the pancreas does not produce enough insulin (Type 1 diabetes) or the body’s cells become resistant to insulin’s effects (Type 2 diabetes). Humulin R provides exogenous insulin to help lower blood sugar levels and manage diabetes.
Manufacturer:
Humulin R 100 IU/ml Vial is manufactured by Lilly, a leading pharmaceutical company known for its expertise in diabetes care and insulin therapy. Lilly is dedicated to producing high-quality medications to improve the lives of people with diabetes worldwide.
Strength and Formulation:
Each vial of Humulin R contains 10 milliliters (ml) of solution, with a concentration of 100 International Units (IU) of insulin per milliliter. The solution is formulated for subcutaneous injection using insulin syringes or insulin pens. Humulin R is a clear, colorless solution that should be inspected visually for particulate matter or discoloration before use.
Indications:
Humulin R is indicated for the treatment of diabetes mellitus in adults and children. It is used to lower blood sugar levels and control hyperglycemia (high blood sugar) in individuals with Type 1 diabetes, Type 2 diabetes, or gestational diabetes. Humulin R may be used alone or in combination with other types of insulin or oral antidiabetic medications as part of a comprehensive diabetes management plan.
Usage and Dosage:
The dosage of Humulin R may vary depending on factors such as the patient’s blood sugar levels, diet, exercise regimen, and individual insulin sensitivity. It is usually administered subcutaneously before meals to control postprandial (after-meal) blood sugar spikes. The specific dosage regimen and injection technique should be determined by a healthcare provider based on individual patient characteristics and treatment goals.
Storage Conditions:
Humulin R vials should be stored according to the manufacturer’s instructions, typically in a refrigerator at a temperature between 2°C to 8°C (36°F to 46°F). Once opened, the vial can be kept at room temperature (below 30°C or 86°F) for up to 28 days. Avoid exposure to direct heat, light, or freezing temperatures. Insulin should not be used if it has been frozen or if it appears cloudy, discolored, or contains visible particles.
Patients should consult their healthcare provider or diabetes educator for personalized information regarding the use of Humulin R, including dosage adjustments, injection techniques, blood glucose monitoring, and hypoglycemia management. Regular follow-up appointments are essential to evaluate treatment response and adjust insulin therapy as needed.
Reviews
There are no reviews yet.